A Case Series of HCV Genotype 1a Infection Patients With HIV Co-infection Treated With 8 Weeks of Ledipasvir-Sofosbuvir

被引：0
作者：
Umar, Shifa [1 ]
Hsiao, Chiu-Bin [1 ]
机构：
[1] Allegheny Hlth Network, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-02128
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2127
引用
收藏
页码：S1179 / S1179
页数：1
相关论文
共 50 条
  • [31] Ledipasvir-sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial
    Rockstroh, Juergen K.
    Bhagani, Sanjay
    Hyland, Robert H.
    Yun, Chohee
    Dvory-Sobol, Hadas
    Zheng, Wei
    Brainard, Diana M.
    Ingiliz, Patrick
    Lutz, Thomas
    Boesecke, Christoph
    Nelson, Mark
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (05) : 347 - 353
  • [32] Effectiveness of 8 weeks of ledipasvir/sofosbuvir for hepatitis C in HCV-HIV-coinfected patients
    Vega, Ana D.
    Hynicka, Lauren M.
    Claeys, Kimberly
    Chua, Joel, V
    Heil, Emily L.
    ANTIVIRAL THERAPY, 2019, 24 (01) : 11 - 17
  • [33] Efficacy and safety of 6 or 8weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection
    Sulkowski, M. S.
    Feld, J. J.
    Lawitz, E.
    Felizarta, F.
    Corregidor, A. M.
    Khalid, O.
    Ghalib, R.
    Smith, W. B.
    Van Eygen, V.
    Luo, D.
    Vijgen, L.
    Gamil, M.
    Kakuda, T. N.
    Ouwerkerk-Mahadevan, S.
    Van Remoortere, P.
    Beumont, M.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (06) : 631 - 639
  • [34] LEDIPASVIR/SOFOSBUVIR FOR 12 OR 24 WEEKS IS SAFE AND EFFECTIVE IN KIDNEY TRANSPLANT RECIPIENTS WITH CHRONIC GENOTYPE 1 OR 4 HCV INFECTION
    Colombo, M.
    Aghemo, A.
    Liu, L.
    Hyland, R.
    Yun, C.
    Brainard, D.
    McHutchison, J.
    Bourliere, M.
    Peck-Radosavljevic, M.
    Manns, M.
    Pol, S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S183 - S183
  • [35] High Rates of SVR in Treatment-Experienced Patients with Genotype 1 HCV Infection and Cirrhosis After Treatment with Ledipasvir/Sofosbuvir and Vedroprevir with or Without Ribavirin for 8 weeks
    Lawitz, Eric
    Poordad, Fred
    Hyland, Robert H.
    Liu, Lin
    Dvory, Hadas S.
    Pang, Phillip S.
    Brainard, Diana M.
    Gutierrez, Julio A.
    HEPATOLOGY, 2015, 62 : 337A - 337A
  • [36] Diabetes Mellitus in HIV/HCV Co-Infected Patients Treated with Ledipasvir and Sofosbuvir
    Bhatti, Zabeer
    Gill, Dalvir
    Virk, Jaswinder
    Sivalingam, Devamohan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1360 - S1360
  • [37] HIV co-infection and risk of morbidity and mortality in HCV patients treated by DAA
    Chalouni, Mathieu
    Pol, Stanislas
    Sogni, Philippe
    Fontaine, Helene
    Lacombe, Karine
    Lacombe, Jean-Marc
    Esterle, Laure
    Gilbert, Camille
    Celine, Dorival
    Salmon-Ceron, Dominique
    Carrat, Fabrice
    Wittkop, Linda
    JOURNAL OF HEPATOLOGY, 2020, 73 : S105 - S106
  • [38] Effectiveness of Ledipasvir-Sofosbuvir 12 Weeks After Hepatitis C Virus Genotype 1 Infection and the Factors Associated With Sustained Virologic Response: A Retrospective Study
    Alshoaibi, Ismaeel A.
    Al-Gamli, Abdullah
    Abdullah, Mohammed
    Abdo, Basheer
    Alzanen, Khaled H.
    Alhakamy, Mohammed
    Al-Namer, Mamoon
    Ahmed, Faisal
    Tamesh, Munther
    Mahdi, Wadhah
    Abdo, Zeyad
    Mohammed, Marwa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [39] Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens
    Wyles, David
    Pockros, Paul
    Morelli, Giuseppe
    Younes, Ziad
    Svarovskaia, Evguenia
    Yang, Jenny C.
    Pang, Phillip S.
    Zhu, Yanni
    McHutchison, John G.
    Flamm, Steven
    Lawitz, Eric
    HEPATOLOGY, 2015, 61 (06) : 1793 - 1797
  • [40] Real world effectiveness of ledipasvir/sofosbuvir (LDV/SOF) for 8 weeks in patients coinfected with HCV and HIV-1
    Buggisch, P.
    Moreno, A.
    Isakov, V.
    Backus, L.
    Ain, D.
    Ruane, P.
    Gonzalez, J.
    Naik, S.
    Mehta, S.
    Lee, J.
    Mertens, M.
    Natha, M.
    Kersey, K.
    Osinusi, A.
    Zhdanov, K.
    Berenguer, J.
    Zeuzem, S.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S729 - S730
12345